top of page

Donations

EFMINT request grants from companies and other institutions to enable best education in INR.

Minimally invasive therapy is a recent development in Medicine and the progression of conventional surgery. It is based on treatments without extensive 'open' surgery using natural portals and accurate navigation in 3-dimensions to access deep structures in the body. Various systems can perform treatments, including the removal of tumors and ablation of local diseases.

Over the last 25 years, this approach has revolutionized medical therapy in nearly all parts of the body but nowhere more profoundly than in the brain and spine. The European Foundation of Minimally Invasive Neurological Therapy was established to prompt minimally invasive therapy for the central nervous system's diseases to alleviate human suffering using the least invasive methods. The Foundation is based in the Swiss capital's canton of Bern and governed by Switzerland's federal laws for charitable foundations.

The mission of the European Foundation of Minimally Invasive Neurological Therapy is to promote the development and provision of minimally invasive therapies. It supports research and education in the specialty. The Foundations accepts donations for this purpose and supervises the provision of support following its rules. The Board members are unanimous in their dedication to acting without cultural, racial, and other types of prejudice and following the highest ethical and scientific rigor standards.

Why support? 

The Foundation of ESMINT (European Society of Minimally Invasive Neurological Therapy) is a non-profit organization that supports research and education in the field of minimally invasive neurological therapy. There are several reasons why a medtech company may choose to support the Foundation of ESMINT:

  1. Access to leading experts: ESMINT is composed of leading experts in the field of minimally invasive neurological therapy. By supporting the Foundation of ESMINT, a medtech company can gain access to this expertise and potentially collaborate with these experts on research and development projects.

  2. Promoting the use of new technologies: The Foundation of ESMINT is focused on promoting the latest advances in minimally invasive neurological therapy, including new technologies and techniques. A medtech company that supports the Foundation of ESMINT can help promote the use of their products and services among neurologists and other healthcare professionals.

  3. Staying current on industry trends: The Foundation of ESMINT regularly organizes events and conferences, providing an opportunity for the medtech company to stay informed about the latest trends and developments in the field of minimally invasive neurological therapy and to network with other companies and professionals.

  4. Building reputation: Supporting the Foundation of ESMINT can help a medtech company build a reputation as a leader in the field of minimally invasive neurological therapy and a company that is committed to advancing the field.

  5. Improving patient care: By supporting the Foundation of ESMINT, a medtech company can contribute to the advancement of minimally invasive neurological therapy and ultimately improve the care and outcomes of patients suffering from neurological conditions.

  6. Tax benefits: Medtech companies that financially support the Foundation of ESMINT may be eligible for tax benefits, depending on the country and the legal framework.

It's worth noting that supporting the Foundation of ESMINT can be a mutually beneficial relationship, where the medtech company can gain access to the expertise and network of ESMINT, while the Foundation of ESMINT can benefit from the support and resources provided by the medtech company.

Donations

EFMINT thanks the following companies for their support in our activities.

logo medtronic.jpeg
logo cerenovus.png
logo acandis.jpeg
Medtronic supports our EastMINT activity
Cerenovus supports our e-fellowship activity
Acandis supports our MENC 2020 educational meeting
bottom of page